Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Narrowband UVB therapy significantly improved a child's rare skin condition.

Bhamrung-Lohit may help with inflammation and oxidation.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

Low-energy laser therapy can improve scalp alopecia treatment when combined with classical methods.

The combination treatment showed a higher response rate but no significant survival benefits.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

The document's conclusion cannot be provided because the content is not available.

BLMP-1 is important for regular molting and gene expression cycles in worms.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Linear cutaneous lupus erythematosus on the scalp is rare, often affects young Asians, and can be treated with specific medications.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

A woman's hair loss and skin discoloration were found to be caused by a rare case of leprosy on the scalp, not alopecia-vitiligo overlap.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Endoscopic brow-lift is effective and well-tolerated, with high patient satisfaction and improved appearance.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.